How pharmacists can improve the care of vulnerable patients Specialist pharmacists discuss the issues surrounding vulnerable patient groups at the RPS annual conference.…
BioCryst remains hopeful of FDA approval for its single-dose influenza drug despite mixed results An experimental single-dose influenza drug has demonstrated mixed results in treating adult patients with flu when administered within 48 hours of the onset of symptoms.…
Efforts to counter climate change-related health risks need to be put centre stage, says WHO President of the World Bank Group Jim Yong Kim calls for action on climate change, saying most serious impacts will be on public health.…
World’s most expensive drug gets green light from NICE The National Institute for Health and Care Excellence has paved the way for making the most expensive drug in the world available on the NHS.…
Self-management effective for people with hypertension A new study shows that people who manage their own hypertension appear to have better control of the condition.…
Novel heart failure therapy shows “overwhelming benefit”, trial shows A novel treatment for heart failure could save the lives of 20% more patients than the current gold-standard therapy.…
Ten-year study by Takeda calls into question pioglitazone’s link with bladder cancer Use of the diabetes drug pioglitazone is not associated with an increased risk of bladder cancer, the drug’s manufacturer Takeda has claimed.…
Pharmacy-led flu vaccination programme put on hold after GPs object GPs in Shropshire and Staffordshire have objected to plans to allow pharmacists to deliver an influenza vaccination programme targeting at-risk patients.…
Potassium-rich diet reduces risk of stroke in postmenopausal women Postmenopausal women who have a diet rich in potassium are less likely to suffer a stroke than women who eat less dietary potassium, suggests research.…
Drug manufacturers must provide accurate shelf life limits Hospital pharmacists are calling on drug manufacturers to include more accurate shelf life limits on compounded parenteral products.…